Sharay Anti-Endothelial Cell IgG (CLIA)

Primary DI

06975070766498

Basic UDI-DI Code

B-06975070766498

Reference

14000436

Device Types

Single use

Regulation

Eu Ivdd

Classification

Eu Ivd General

Status

On The Market

Manufacturer

C-Luminary Biotechnology Co., Ltd.

Sharay Anti-Endothelial Cell IgG (CLIA) is intended for the In Vitro qualitative measurement of IgG directed to AECA in human serum/plasma as an aid in the diagnosis of primary and secondary autoimmune vasculitis, idiopathic renal vasculitis, SLE, APS, RA associated vasculitis, mixed connective tissue disease and primary sjogren's syndrome in conjunction with other laboratory and clinical findings.

Other on-the-market devices with the same classification (Eu Ivd General) and regulation (EU IVDD).